Home › Presage Biosciences In-Licenses Clinical Stage Drug Program
 

Keywords :   


Presage Biosciences In-Licenses Clinical Stage Drug Program

2015-12-02 02:08:44| drugdiscoveryonline Home Page

Presage Biosciences, an oncology company pioneering a radical new drug development approach that incorporates human efficacy data much earlier in development and clinical trials, announced recently that it has in-licensed voruciclib, its first clinical stage drug program

Tags: program stage drug clinical

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
24.04Beiersdorf AG Forges Multi-Year Partnership with Rubedo Life Sciences
24.04Squalene Market Size Positioned to Grow by $64.75 Million by 2027
24.04Outcry led to HMRC's helpline closure U-turn
24.04Perfect Corp.: Q1 2024 Financials
24.04Seattles Climate Pledge Arena Earns TRUE Platinum Certificate for Impressive Waste Diversion Rate
24.04rePurpose Global Broadens Platform with Acquisition of Bluebird Climate
24.04Aveda Develops Care for Curls and Coils
24.04New Door-to-Door Service in East Bay, CA Area Collects Household Recycling Usually Excluded from Curbside Collection
More »